in a double-blind randomized study , hydralazine ( n = 59 ) or the new dihydropyridine calcium antagonist felodipine ( n = 61 ) was added to previous treatment with beta-adrenoceptor blocking agents in a group of 120 patients with essential hypertension .
C2945601
dihydropyridine calcium antagonist
C0015772
felodipine